Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.15%165.89B | 14.03%701.77B | 3.64%180.82B | 9.80%177.18B | 23.11%177.65B | 22.79%166.13B | 32.23%615.42B | 35.69%174.46B | 33.65%161.36B | 33.59%144.3B |
Cost of revenue | -0.21%123.46B | 9.37%522.05B | 1.95%137.27B | 5.08%129.49B | 18.38%131.58B | 14.21%123.71B | 31.72%477.34B | 32.31%134.63B | 31.06%123.23B | 33.35%111.15B |
Gross profit | 0.03%42.43B | 30.15%179.72B | 9.34%43.55B | 25.08%47.69B | 38.96%46.07B | 57.24%42.41B | 34.02%138.08B | 48.53%39.83B | 42.73%38.13B | 34.40%33.15B |
Operating expense | 10.37%35.42B | 11.14%137.12B | 13.42%36.92B | 8.83%34.46B | 10.01%33.65B | 12.32%32.09B | 24.07%123.38B | 24.23%32.55B | 25.15%31.66B | 25.83%30.59B |
Operating profit | -32.10%7.01B | 189.64%42.6B | -8.90%6.63B | 104.62%13.24B | 384.77%12.42B | 745.99%10.32B | 309.38%14.71B | 1,083.41%7.28B | 356.78%6.47B | 619.38%2.56B |
Net non-operating interest income (expenses) | -21.17%-1.31B | -76.77%-5.44B | -42.68%-1.87B | -47.73%-1.24B | -134.51%-1.26B | -173.35%-1.08B | -233.84%-3.08B | -424.80%-1.31B | -265.07%-836M | -139.29%-536M |
Non-operating interest income | 64.86%455M | 81.51%1.44B | 62.65%405M | 140.78%496M | 48.60%266M | 71.43%276M | 41.21%795M | 76.60%249M | 57.25%206M | 20.95%179M |
Non-operating interest expense | 30.08%1.76B | 77.74%6.88B | 45.87%2.28B | 66.12%1.73B | 113.01%1.52B | 143.78%1.35B | 160.81%3.87B | 299.23%1.56B | 189.44%1.04B | 92.20%715M |
Net investment income | -76.25%76M | 343.43%241M | 0 | 50.00%-246M | -46.65%167M | -26.94%320M | -136.53%-99M | -590.41%-358M | -500.00%-492M | 1,404.17%313M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 84M | 420.00%208M | 316.67%200M | 600.00%7M | 111.11%1M | 0 | 263.64%40M | 48M | -90.91%1M | -9M |
Income from associates and other participating interests | -850.00%-30M | -72.62%23M | -561.54%-60M | -68.18%7M | 350.00%72M | -87.88%4M | 663.64%84M | 62.50%13M | 540.00%22M | 23.08%16M |
Special income (charges) | 3,719.21%5.77B | -289.45%-1.06B | -1,408.62%-875M | -137.50%-396M | 306.67%61M | 133.26%151M | 233.41%559M | 74.78%-58M | 7,642.86%1.06B | 160.00%15M |
Less:Restructuring and mergern&acquisition | --0 | 604.96%853M | 515.70%745M | --1M | --3M | --104M | -32.40%121M | --121M | --0 | --0 |
Less:Other special charges | -1,930.63%-5.77B | 126.03%177M | 306.35%130M | 137.41%395M | -326.67%-64M | -162.56%-284M | -1,085.51%-680M | -223.53%-63M | -7,642.86%-1.06B | -160.00%-15M |
Less:Write off | --0 | --29M | --0 | --0 | --0 | --29M | --0 | --0 | --0 | --0 |
Other non-operating income (expenses) | 1.69%60M | 75.86%51M | -53.33%-69M | 26M | 40.00%35M | 20.41%59M | -89.86%29M | -193.75%-45M | 0 | -78.63%25M |
Income before tax | 19.23%11.66B | 199.17%36.63B | -28.99%3.95B | 83.43%11.4B | 381.48%11.49B | 607.52%9.78B | 332.31%12.24B | 2,017.11%5.57B | 374.07%6.22B | 1,000.00%2.39B |
Income tax | 22.56%3.87B | 68.97%9.08B | -28.42%1.03B | 65.16%3.37B | -33.35%1.53B | 918.91%3.16B | 157.40%5.37B | 1,450.94%1.43B | 107.96%2.04B | 1,546.04%2.29B |
Net income | 17.65%7.79B | 300.95%27.55B | -29.18%2.93B | 92.36%8.03B | 9,969.70%9.97B | 529.74%6.62B | 823.52%6.87B | 1,020.87%4.14B | 1,161.63%4.18B | 30.26%99M |
Net income continuous operations | 17.65%7.79B | 300.96%27.55B | -29.18%2.93B | 92.34%8.03B | 9,968.69%9.97B | 529.53%6.62B | 822.28%6.87B | 1,020.87%4.14B | 1,161.93%4.18B | 26.92%99M |
Noncontrolling interests | -60.00%4M | 169.05%29M | 87.50%-2M | 163.64%7M | 193.33%14M | 10M | -255.56%-42M | -700.00%-16M | -191.67%-11M | -207.14%-15M |
Net income attributable to the company | 17.75%7.78B | 298.09%27.52B | -29.39%2.93B | 91.67%8.03B | 8,708.85%9.95B | 529.37%6.61B | 864.16%6.91B | 1,018.87%4.15B | 1,208.75%4.19B | 85.25%113M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 17.75%7.78B | 298.09%27.52B | -29.39%2.93B | 91.67%8.03B | 8,708.85%9.95B | 529.37%6.61B | 864.16%6.91B | 1,018.87%4.15B | 1,208.75%4.19B | 85.25%113M |
Gross dividend payment | ||||||||||
Basic earnings per share | 17.82%73 | 298.12%258.06 | -29.42%27.47 | 91.65%75.28 | 8,706.60%93.35 | 529.09%61.96 | 863.15%64.82 | 1,018.39%38.92 | 1,209.33%39.28 | 79.66%1.06 |
Diluted earnings per share | 17.84%72.78 | 298.22%257.29 | -29.27%27.45 | 91.07%75.03 | 8,682.17%93.05 | 527.70%61.76 | 864.33%64.61 | 1,021.68%38.81 | 1,213.32%39.2683 | 85.15%1.0595 |
Dividend per share | 0 | 122.22%20 | 122.22%20 | 0 | 0 | 0 | 12.50%9 | 12.50%9 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |